Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE

Melinda J. Gooderham, Chia Yu Chu, Ricardo Rojo, Hernan Valdez, Pinaki Biswas, Michael C. Cameron, Claire Feeney, Gerardo A. Encinas, Kathleen Peeples-Lamirande, Joseph C. Cappelleri, Daniela E. Myers, Marco DiBonaventura

Research output: Contribution to journalArticlepeer-review

9 Scopus citations
Original languageEnglish
Pages (from-to)46-48
Number of pages3
JournalJAAD International
StatePublished - Sep 2021
Externally publishedYes


  • abrocitinib
  • atopic dermatitis
  • combination therapy
  • cost
  • economic impact
  • monotherapy

Cite this